Response Inhibition Training for Obsessive-Compulsive Disorder
(OCRD Trial)
Trial Summary
What is the purpose of this trial?
This trial tests a computer-based training program to help people with OCD, hair-pulling, and skin-picking disorders improve their self-control. The training aims to strengthen brain areas that help stop inappropriate actions, potentially reducing symptoms.
Will I have to stop taking my current medications?
The trial requires that you do not change your psychotropic medication status within 8 weeks before or during the study. If you are on stimulant medication, you may need to stop taking it to participate.
What data supports the effectiveness of the treatment Response Inhibition Training for Obsessive-Compulsive Disorder?
Research suggests that combining computerized cognitive training with traditional therapy methods like exposure and response prevention (ERP) can improve treatment outcomes for obsessive-compulsive disorder (OCD). Additionally, computer-assisted therapy has been shown to be effective and can reduce the need for therapist contact, making it a promising option for OCD treatment.12345
Is response inhibition training safe for humans?
How is Response Inhibition Training different from other treatments for OCD?
Research Team
Hanjoo Lee, Ph.D.
Principal Investigator
University of Wisconsin, Milwaukee
Christine Larson, Ph.D.
Principal Investigator
University of Wisconsin, Milwaukee
Eligibility Criteria
This trial is for adults aged 18-60 with moderate to severe obsessive-compulsive or related disorders (OCRD), such as OCD, trichotillomania, or skin picking disorder. Participants should have certain levels of symptoms measured by specific scales and a deficit in response inhibition. They must not have psychotic disorders, bipolar disorder, schizophrenia, high suicide risk, MRI contraindications, substance use issues, severe ADHD or recent changes in psychotropic meds.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment Phase I
Participants undergo 8 to 16 sessions of computerized Response Inhibition Training (RIT) or placebo training, with neurobehavioral measures taken pre- and post-training.
Follow-up
Participants are monitored for safety and effectiveness after treatment, with data collected on functional outcomes.
Treatment Phase II
Similar to Phase I, participants undergo additional sessions of RIT or placebo training, focusing on reduction in OCRD symptoms.
Treatment Details
Interventions
- Computerized cognitive training
- Computerized placebo training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Wisconsin, Milwaukee
Lead Sponsor